EVALUATION OF SF-PS-TURBIDIMETRY IN DETERMINATION OF SOLUBLE FIBRIN, COMPARISON WITH D-DIMERS AND FIBRIN(OGEN) DEGRADATION PRODUCTS FOR DETECTION OF FIBRINOGEN FIBRIN TURNOVER IN PATIENTS

被引:0
|
作者
WIEDING, JU
EISINGER, G
KOSTERING, H
机构
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:305 / 310
页数:6
相关论文
共 35 条
  • [21] DETECTION OF SERUM FIBRINOGEN AND FIBRIN DEGRADATION PRODUCTS - COMPARISON OF 6 TECHNICS USING PURIFIED PRODUCTS AND APPLICATION IN CLINICAL STUDIES
    MARDER, VJ
    MATCHETT, MO
    SHERRY, S
    AMERICAN JOURNAL OF MEDICINE, 1971, 51 (01): : 71 - &
  • [22] MEASURING PLASMA-FIBRINOGEN LEVELS IN PATIENTS WITH LIVER-CIRRHOSIS - THE OCCURRENCE OF PROTEOLYTIC FIBRIN(OGEN) DEGRADATION PRODUCTS AND THEIR INFLUENCE ON SEVERAL FIBRINOGEN ASSAYS
    DEMAAT, MPM
    NIEUWENHUIZEN, W
    KNOT, EAR
    VANBUUREN, HR
    SWART, GR
    THROMBOSIS RESEARCH, 1995, 78 (04) : 353 - 362
  • [23] Comparison of the serum fibrin-fibrinogen degradation products with cytokeratin 19 fragment as biomarkers in patients with lung cancer
    So, Hee Jin
    Hong, Seok-Il
    Lee, Jin Kyung
    Chang, Yoon Hwan
    Kang, Sun Jung
    Hong, Young Jun
    BIOMEDICAL REPORTS, 2014, 2 (05) : 737 - 742
  • [24] Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients
    Xiong Wei-Xin
    Shen Ying
    Dai Dao-Peng
    Lu Lin
    Zhang Qi
    Zhang Rui-Yan
    Shen Wei-Feng
    Tao Rong
    中华医学杂志英文版, 2015, 128 (06) : 727 - 732
  • [25] Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients
    Xiong, Wei-Xin
    Shen, Ying
    Dai, Dao-Peng
    Lu, Lin
    Zhang, Qi
    Zhang, Rui-Yan
    Shen, Wei-Feng
    Tao, Rong
    CHINESE MEDICAL JOURNAL, 2015, 128 (06) : 727 - 732
  • [26] AGE AND FUNCTIONAL CORRELATIONS OF MARKERS OF COAGULATION AND INFLAMMATION IN THE ELDERLY - FUNCTIONAL IMPLICATIONS OF ELEVATED CROSS-LINKED FIBRIN DEGRADATION PRODUCTS (D-DIMERS)
    CURRIE, MS
    RAO, KMK
    BLAZER, DG
    COHEN, HJ
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1994, 42 (07) : 738 - 742
  • [27] Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study
    Godon, Alexandre
    Durand, Zoe
    Agier, Lydiane
    Lecompte, Thomas
    Mullier, Francois
    Marlu, Raphael
    de Maistre, Emmanuel
    Tacquard, Charles
    Levy, Jerrold H.
    Godier, Anne
    Susen, Sophie
    Albaladejo, Pierre
    Godier, Anne
    Susen, Sophie
    Albaladejo, Pierre
    THROMBOSIS RESEARCH, 2021, 205 : 8 - 10
  • [28] THE DEVELOPMENT AND EVALUATION OF A NEW METHOD FOR MEASURING PLASMA FIBRINOGEN-FIBRIN DEGRADATION PRODUCTS USING D2C STAPHYLOCOCCUS
    MUNRO, R
    MEDICAL LABORATORY SCIENCES, 1981, 38 (02): : 143 - 143
  • [29] New anti-fragment D Monoclonal antibody coated latex reagents for detection of fibrinogen/fibrin degradation products (FDP) and D-dimer in plasma.
    Matsushita, H
    CLINICAL CHEMISTRY, 2003, 49 (06) : A5 - A5
  • [30] DETERMINATION OF CROSS-LINKED FIBRIN DEGRADATION PRODUCTS (D-DIMER) BEFORE AND AFTER STIMULATION WITH ALTEPLASE IN PATIENTS WITH OR WITHOUT DEEP VENOUS THROMBOSIS
    LANDORPH, A
    NIELSEN, JD
    MOLLERUP, H
    JORGENSEN, B
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1100 - 1100